Research Topic · Peer-Reviewed

Cyclophosphamide

Cyclophosphamide is an antineoplastic drug used to treat cancer. It works by interfering with the growth of cancer cells, either stopping or slowing their growth. Cyclophosphamide can be used as part of combination chemo-therapy regimens for a wide variety of cancer types, including breast, lung, bladder, ovary and …

Curated from this journal's research 📚 8 peer-reviewed articles cited Cited 24× across the literature 🗓 Reviewed June 2026

Overview

Cyclophosphamide is an antineoplastic drug used to treat cancer. It works by interfering with the growth of cancer cells, either stopping or slowing their growth. Cyclophosphamide can be used as part of combination chemo-therapy regimens for a wide variety of cancer types, including breast, lung, bladder, ovary and leukemia. Its primary side effects include nausea, vomiting, fatigue, alopecia (hair loss), and increased risk of infection. Its use is an important part of cancer treatment, as it has been found to be effective in reducing morbidity and mortality.

Research published in this journal

8 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 8 articles above have been cited 24 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Cyclophosphamide, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in International Journal of Chemotherapy Research and Practice.

Journal editorial board
Monika Sakowicz-Burkiewicz · Poland M. Waheed Roomi · United States Silvia Lemma · Italy

This page summarises published research for orientation; it is not medical or professional advice.